CXCL12 and malignant colon neoplasm: In breast and colon cancer, lower intrinsic levels of the chemoattractant chemokine CXCL12 due to hypermethylation of its promoter disrupt cellular feedback mechanisms to internalize membranous CXCR4 [14, 15].